Large-scale SNP scoring from unamplified genomic DNA

Pharmacogenomics

Volumn 1, Issue 2, 2000, Pages 219-229

  Fors, Lance ^a   Lieder, Kafryn W ^a   Vavra, Stephanie H ^a   Kwiatkowski, Robert W ^a  

^a Third Wave Technologies Inc   (United States)

Author keywords

Automation; Cleavase enzyme; FEN; Flap endonuclease; FRET; Genetic disease; High throughput; High throughput screening (HTS); Homogeneous; Human Genome Project; Invader assay; Polymorphism; Single nucleotide polymorphism (SNP)

Indexed keywords

DNA;

GENETICS; HUMAN; HUMAN GENOME PROJECT; MUTATION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

DNA; HUMAN GENOME PROJECT; HUMANS; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 0034189085     PISSN: 14622416     EISSN: None     Source Type: Journal    
DOI: 10.1517/14622416.1.2.219     Document Type: Review

References (52)

1. DUNHAM I, SHIMIZU N, ROE BA, CHISSOE S E: The DNA sequence of human chromosome 22. Nature (1999) 402:489-495.
2. BROOKES AJ: The essence of SNPs. Gene (1999) 234:177-186.
3. ISAKSSON A, LANDEGREN U: Accessing genomic information: alternatives to PCR. Curr. Opin. Biotechnol. (1999) 10:11-15.
4. BELL J: Medical implications of understanding complex disease traits. Curr. Opin. Biotechnol. (1998) 9:573-577.
5. LANDEGREN U: Molecular mechanics of nucleic acid sequence amplification. Trends Genet (1993) 9:199-204.
6. COTTON RG, MCKUSICK V, SCRIVER CR: The Hugo mutation database initiative [letter] [published erratum appears in Science (13 Feb 1998) 279(5353):969]. Science (1998) 279:10-11.
7. WHITCOMBE D, NEWTON CR, LITTLE S: Advances hi approaches to DNA-based diagnostics. Curr. Opin. Biotechnol. (1998) 9:602-608.
8. CANTOR CR, OPELLA SJ: Analytical biotechnology. Curr. Opin. Biotechnol. (1999) 10:9-10.
9. HESSNER MJ, LUHM RA, PEARSON SL, ENDEAN DJ, FRIEDMAN KD, MONTGOMERY RR: Prevalence of prothrombin G2021A, Factor V G1691A (Leiden) and methylenetetrahydrofolate reductase (MTHFR) C677T in seven different populations determined by multiplex allele-specific PCR. Thromb. Haemost. (1999) 81:733-738.
10. SCHAFER AJ, HAWKINS JR: DNA variation and the future of human genetics. Nature Biotechnol (1998) 16:33-39.
11. FROST S: DNA probes mutating from research tool to competitive clinical diagnostic. (17 August 1999) Press Release.
12. PASTINEN T, KURG A, METSPALU A, PELTONEN L, SYVANEN AC: Minisequencing: a specific tool for DNA analysis and diagnostics on oligonucleotide arrays. Genome Res. (1997) 7:606-614.
13. WANG DG, FAN JB, SIAO CJ et al.: Large-scale Identification, mapping and genotyping of single-nucleotide polymorphisms in the human genome. Science (1998) 280:1077-1082.
14. LANDEGREN U, NILSSON M, KWOK P-Y: Reading bits of genetic information: methods for single-nucleotide polymorphism analysis. Genome Res. (1998) 8:769-776.
15. SAIKI RK, SCHARF SJ, FALOONA F et al.: Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science (1985) 230:1350-1354.
16. EHRLICH GD: PCR Based Diagnostics and Infectious Disease. Ehrlich GSJ (Ed.), Blackwell Scientific Publications, Oxford, UK (1994):3-18.
17. WALSH PS, ERLICH HA, HIGUCHI R: Preferential PCR amplification of alleles: mechanisms and solutions. PCR Methods Appl. (1992) 1:241-250.
18. BARNARD R, FUTO V, PECHENIUK N, SLATTERY M, WALSH T: PCR bias toward the wild-type k-ras and p53 sequences: implications for PCR detection of mutations and cancer diagnosis. Biotechniques (1998) 25:684-691.
19. WU DY, UGOZZOLI L, PAL BK, WALLACE RB: Allele-specific enzymatic amplification of beta-globin genomic DNA for diagnosis of sickle cell anemia. Proc. Natl. Acad. Sci. USA (1989) 86:2757-2760.
20. LANDEGREN U, KAISER R, SANDERS J, HOOD L: A ligase-mediated gene detection technique. Science (1988) 241:1077-1080.
21. KWOK P-Y, GREMAUD MF, NICKERSON DA, HOOD L, OLSON MV: Automatable screening of yeast artificial-chromosome libraries based on the oligonucleotide-ligation assay. Genomics (1992) 13:935-941.
22. BARANY F: The ligase chain reaction in a per world [published erratum appears in PCR Methods Appl. (Nov 1991) 1(2):149]. PCR Methods Appl. (1991) 1:5-16.
23. WALTER NG, STRUNK G: Strand displacement amplification as an in vitro model for rolling-circle replication: deletion formation and evolution during serial transfer. Proc. Natl. Acad. Sci. USA (1994) 91:7937-7941.
24. TOBE VO, TAYLOR SL, NICKERSON DA: Single-well genotyping of diallelic sequence variations by a two-color elisa-based oligonucleotide ligation assay. Nucleic Acids Res. (1996) 24:3728-3732.
25. CHEN X, LIVAK KJ, KWOK PY: A homogeneous, ligase-mediated DNA diagnostic test. Genome Res. (1998) 8:549-556.
26. SHUBER AP, MICHALOWSKY LA, NASS GS et al.: High throughput parallel analysis of hundreds of patient samples for more than 100 mutations in multiple disease genes. Hum. Mol. Genet. (1997) 6:337-347.
27. CHEE M, YANG R, HUBBELL E et al.: Accessing genetic information with high-density DNA arrays. Science (1996) 274:610-614.
28. DRMANAC S, KITA D, LABATI et al.: Accurate sequencing by hybridization for DNA diagnostics and individual genomics. Nature Biotechnol (1998) 16:54-58.
29. TYAGI S, BRATU DP, KRAMER FR: Multicolor molecular beacons for allele discrimination. Nature Biotechnol. (1998) 16:49-53-
30. LIVAK KJ, FLOOD SJ, MARMARO J, GIUSTI W, DEETZ K: Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting per product and nucleic acid hybridization. PCR Methods Appl. (1995) 4:357-362.
31. HOLLAND PM, ABRAMSON RD, WATSON R, GELFAND DH: detection of specific polymerase chain reaction product by utilizing the 5′-3′ exonuclease activity of thermits aquaticus DNA polymcrase. Proc. Natl. Acad. Sci. USA (1991) 88:7276-7280.
32. SANGER F, NICKLEN S, COULSON AR: DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA (1977) 74:5463-5467.
33. MAXAM AM, GILBERT W: Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol. (1980) 65:499-560.
34. DE MARTINVILLE B, WYMAN AR, WHITE R, FRANCKE U: Assignment of first random restriction fragment length polymorphism (RFLP) locus (D14s1) To a region of human chromosome 14. Am. J. Hum. Genet. (1982) 34:216-226.
35. LANDEGREN U, SAMIOTAKI M, NILSSON M, MALMGREN H, KWIATKOWSKI M: Detecting genes with ligases. Methods (1996) 9:84-90.
36. NILSSON M, KREJCI K, KOCH J, KWIATKOWSKI M, GUSTAVSSON P, LANDEGREN U: Padlock probes reveal single-nucleotide differences, parent of origin and in situ distribution of centromeric sequences in human chromosomes 13 and 21. Nature Genet. (1997) 16:252-255.
37. THOMAS DC, NARDONE GA, RANDALL SK: Amplification of padlock probes for DNA diagnostics by cascade rolling circle amplification or the polymerase chain reaction. Arch. Pathol. Lab. Med. (1999) 123:1170-1176.
38. BRONK KS, MICHAEL KL, PANTANO P, WALT DR: Combined imaging and chemical sensing using a single optical imaging fiber. Anal. Chem. (1995) 67:2750-2757.
39. BRONK KS, WALT DR: Fabrication of patterned sensor arrays with aryl azides on a polymer- coated imaging optical fiber bundle. Anal. Chem. (1994) 66:3519-3520.
40. LYAMICHEV V, MAST AL, HALL JG et al.: Polymorphism identification and quantitative detection of genomic DNA by invasive cleavage of oligonucleotide probes. Nature Biotechnol. (1999) 17:292-296. This paper is the first discussion of the invasive cleavage reaction, and provides several examples of its success in detecting mutations.
41. PRUDENT JR, MARSHALL DJ, BEATY EL et al.: Invader squared FRET analysis for the direct detection of human genomic alterations. Am. J. Hum. Genet. (1998) 63:A239.
42. CARDULLO RA, AGRAWAL S, FLORES C, ZAMECNIK PC, WOLF DE: Detection of nucleic acid hybridization by nonradiative fluorescence resonance energy transfer. Proc. Natl. Acad. Sci. USA (1988) 85:8790-8794.
43. STRYER L: Fluorescence energy transfer as a spectroscopic ruler. Ann. Rev. Biochem. (1978) 47:819-846.
44. RYAN D, NUCCIE B, ARYAN D: Non-PCR-dependent detection of the factor V leiden mutation from genomic DNA using a homogeneous Invader microtitcr plate assay. Mol. Diagn. (1999) 4:135-144. This paper describes the first use of the invasive cleavage reaction in a clinical study.
45. ™ assay. Mol. Diagn. (1999) 4:353-364. This paper provides a good overview of Invader® technology, and its applicability to many different fields of research and clinical use.
46. KAISER MW, LYAMICHEVA N, MA W et al.: A comparison of eubacterial and archaeal structure-specific 5′-exonucleases. J. Biol. Chem. (1999) 274:21387-21394. This paper describes the characteristics of different enzymes that can function in invasive cleavage reactions.
47. ® assay.
48. http://www.ornl.gov/hgmis/publicat/hgn/v10n3/01hgpdra ft.html HUMAN GENOME PROGRAM: HGP leaders confirm accelerated timetable for draft sequence. (1999).
49. http://www.ncbi.nlm.nih.gov/genome/seq/weekly_report. html NATIONAL CENTER FOR BIOTECHNOLOGY INFORMATION: Human Genome Sequencing Progress Report. (2000).
50. http://www.orrd.gov/hgmis/project/51691jgi.html HUMAN GENOME PROGRAM: Researchers decode three human chromosomes: information may lead to treatments for kidney disease, diabetes, and prostate and colorectal cancer. (2000).
51. http://www.pecorporation.com/press/prccorp011000.html KOWALSKI HE: Celera compiles DNA sequence covering 90% of the human genome. (2000).
52. ™technology: early access program for SNP scoring. (1999).